Takeda Pharmaceutical (TAK) Revenue (2009 - 2026)
Takeda Pharmaceutical (TAK) revenue from Dec 31, 2009 to Mar 31, 2026. The TTM Takeda Pharmaceutical (TAK) revenue is $0. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Quarterly Revenue
Annual Revenue change of Takeda Pharmaceutical (TAK)
| Year | Revenue | Change |
|---|---|---|
| 2026 | $0 | N/A |
| 2025 | $0 | N/A |
| 2024 | $0 | -100.00% |
| 2023 | $7.20B | -49.81% |
| 2022 | $14B | -53.62% |
| 2021 | $31B | +2.51% |
| 2020 | $30B | +1.60% |
| 2019 | $30B | +83.60% |
| 2018 | $16B | +1.68% |
| 2017 | $16B | -0.43% |
| 2016 | $16B | +5.24% |
| 2015 | $15B | -5.59% |
| 2014 | $16B | -3.60% |
| 2013 | $17B | -13.44% |
| 2012 | $19B | +4.08% |
| 2011 | $19B | +12.49% |
| 2010 | $16B | +311.05% |
| 2009 | $4B | N/A |